These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. To the editor: role of synalbumin insulin antagonist in the pathogenesis of diabetes mellitus. Vallance-Owen J; Bajaj JS Metabolism; 1971 May; 20(5):521-7. PubMed ID: 5580875 [No Abstract] [Full Text] [Related]
12. The inhibitory effect of a human serum albumin fraction on insulin activity. Koyama T; Miyamura K; Mizoguchi T Wakayama Med Rep; 1968 Mar; 12(4):193-204. PubMed ID: 5659919 [No Abstract] [Full Text] [Related]
15. [Insulin-inhibiting action of albumin obtained from serum of patients with diabetes and coronary sclerosis]. Kammerer L; Bretán M; Nemesánszky L; Virág S; Jakab L Orv Hetil; 1967 Jun; 108(25):1158-61. PubMed ID: 4965654 [No Abstract] [Full Text] [Related]
16. Failure of synalbumin to exhibit insulin antagonism in vivo. Davidson MB; Goodner CJ Diabetes; 1967 Jun; 16(6):386-94. PubMed ID: 6025265 [No Abstract] [Full Text] [Related]
17. A comparative evaluation of the methods for the study of synalbumin insulin antagonism. Bajaj JS; Bansal DD; Jindal HO; Garg SK Acta Diabetol Lat; 1974; 11(1):26-31. PubMed ID: 4440403 [No Abstract] [Full Text] [Related]
18. Diabetic neuropathy--clinical and electrophysiological study in synalbumin positive and synalbumin negative subjects. Chopra JS; Connon JJ; Banerji NK Diabetologia; 1969 Dec; 5(6):413-5. PubMed ID: 5372894 [No Abstract] [Full Text] [Related]